stars 1 stars 2 stars 3

OxThera, founded in 2005 and headquartered in Stockholm, Sweden, is a biopharmaceutical company with products in late-stage clinical development focusing on Primary and Secondary Hyperoxaluria. OxThera’s intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes.

OxThera Questions

The OxThera annual revenue was $14 million in 2026.

3 people are employed at OxThera.

The NAICS codes for OxThera are [5417, 54, 54171, 541, 541714].

The SIC codes for OxThera are [873, 87].

Top OxThera Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users